Rina Wolf

Axial Biotech, Inc. developed and commercialized genetic tests and treatment solutions for spinal disorders. The company was founded by John T. Braun, James W. Ogilvie, W. Kenneth Ward and John M. Climaco in 2002 and was headquartered in Salt Lake City, UT.

Redpath Partners, Inc. provides complex cancer diagnostic testing for pathologists, oncologists and clinicians. The company was founded by Del Mary Brady and Sydney D. Finkelstein and is headquartered in Pittsburgh, PA.

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Esoterix, Inc. provides laboratory testing services. The company performs esoteric laboratory tests including testing for asthma, bleeding disorders, cancer, diabetes, and infectious diseases. The company was founded in 1995 and is headquartered in Austin, TX.

XIFIN, Inc. engages as a healthcare information technology company. Its products and services include revenue cycle management, laboratory information systems, precision medicine informatics, and digital pathology consultation. The company was founded by L?le White, Donald Lavigne, Michael Coats, and Jeffrey Yates in 1997 and is headquartered in San Diego, CA.

The California Clinical Laboratory Association (CCLA) is an organization that represents both small and large laboratories. The non-profit company is based in Sacramento, CA. The association was formed in November 1976.

American Clinical Laboratory Association is an organization that provides resources to its members who are involved in diagnostic innovation. The non-profit company is based in Washington. The American company works with patients and providers to meet the evolving healthcare needs of the country.

Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA.